GIP and diabetes mellitus: While the exact mechanisms behind the loss of GIP's insulinotropic action in diabetes remains obscure, several lines of experimental evidence suggest that GIPR is substantially down-regulated in pancreatic β-cells under a persistent hyperglycemic condition [13]–[17].